Literature DB >> 20425292

From TADS and SOFTADS to TORDIA and beyond: what's new in the treatment of adolescent depression?

Zheya Jenny Yu1, Christopher J Kratochvil, Ronald A Weller, Mira Mooreville, Elizabeth B Weller.   

Abstract

Major depressive disorder in adolescents is associated with significant morbidity and mortality. Major advances have been made in recent years in the treatment of adolescent depression, with promising outcomes. However, limitations of currently available treatments have prompted attempts to better understand pediatric depression from a broader perspective and to develop more effective treatment strategies in the future.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20425292     DOI： 10.1007/s11920-010-0094-x

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   5.285


  41 in total

1.  Effects of psychotherapy for depression in children and adolescents: a meta-analysis.

Authors:  John R Weisz; Carolyn A McCarty; Sylvia M Valeri
Journal:  Psychol Bull       Date:  2006-01       Impact factor: 17.737

2.  Efficacy of Interpersonal Psychotherapy-Adolescent Skills Training: an indicated preventive intervention for depression.

Authors:  Jami F Young; Laura Mufson; Mark Davies
Journal:  J Child Psychol Psychiatry       Date:  2006-12       Impact factor: 8.982

3.  A randomized trial of a group cognitive intervention for preventing depression in adolescent offspring of depressed parents.

Authors:  G N Clarke; M Hornbrook; F Lynch; M Polen; J Gale; W Beardslee; E O'Connor; J Seeley
Journal:  Arch Gen Psychiatry       Date:  2001-12

Review 4.  Treatment-resistant depression in adolescents: recognition and management.

Authors:  David A Brent; Boris Birmaher
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2006-10

5.  Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS).

Authors:  Benedetto Vitiello; Paul Rohde; Susan Silva; Karen Wells; Charles Casat; Bruce Waslick; Anne Simons; Mark Reinecke; Elizabeth Weller; Christopher Kratochvil; John Walkup; Sanjeev Pathak; Michele Robins; John March
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-12       Impact factor: 8.829

6.  Preventing depression among early adolescents in the primary care setting: a randomized controlled study of the Penn Resiliency Program.

Authors:  Jane E Gillham; John Hamilton; Derek R Freres; Ken Patton; Robert Gallop
Journal:  J Abnorm Child Psychol       Date:  2006-04-29

7.  Preventing adolescent depression: an evaluation of the problem solving for life program.

Authors:  Susan H Spence; Jeanie K Sheffield; Caroline L Donovan
Journal:  J Consult Clin Psychol       Date:  2003-02

8.  Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.

Authors:  David A Brent; Graham J Emslie; Greg N Clarke; Joan Asarnow; Anthony Spirito; Louise Ritz; Benedetto Vitiello; Satish Iyengar; Boris Birmaher; Neal D Ryan; Jamie Zelazny; Matthew Onorato; Betsy Kennard; Taryn L Mayes; Lynn L Debar; James T McCracken; Michael Strober; Robert Suddath; Henrietta Leonard; Giovanna Porta; Martin B Keller
Journal:  Am J Psychiatry       Date:  2009-02-17       Impact factor: 18.112

9.  Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial.

Authors:  Graham J Emslie; John H Heiligenstein; Karen Dineen Wagner; Sharon L Hoog; Daniel E Ernest; Eileen Brown; Mary Nilsson; Jennie G Jacobson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2002-10       Impact factor: 8.829

10.  Relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial.

Authors:  Marisa Elena Domino; E Michael Foster; Benedetto Vitiello; Christopher J Kratochvil; Barbara J Burns; Susan G Silva; Mark A Reinecke; John S March
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-07       Impact factor: 8.829
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.